Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Maren Gaudig"'
Autor:
Laura T. R. Morrison, Benjamin Anderson, Alice Brower, Sandra E. Talbird, Naomi Buell, Pia D. M. MacDonald, Laurent Metz, Maren Gaudig, Valérie Oriol Mathieu, Amanda A. Honeycutt
Publikováno v:
PLoS ONE, Vol 18, Iss 4 (2023)
Introduction Decisions about prevention of and response to Ebola outbreaks require an understanding of the macroeconomic implications of these interventions. Prophylactic vaccines hold promise to mitigate the negative economic impacts of infectious d
Externí odkaz:
https://doaj.org/article/c7b596fe1615497bb065544eaec2d323
Autor:
Adrián Alegre, Javier de la Rubia, Anna Sureda Balari, Cristina Encinas Rodríguez, Alexia Suárez, María Jesús Blanchard, Joan Bargay Lleonart, Paula Rodríguez-Otero, Andrés Insunza, Luis Palomera, María Jesús Peñarrubia, Rafael Ríos-Tamayo, Luis Felipe Casado Montero, Marta Sonia González, Anna Potamianou, Catherine Couturier, Huiling Pei, Henar Hevia, Iordanis Milionis, Maren Gaudig, María-Victoria Mateos
Publikováno v:
HemaSphere, Vol 4, Iss 3, p e380 (2020)
Abstract. Daratumumab is a human CD38-targeted monoclonal antibody approved as monotherapy for heavily pretreated relapsed and refractory multiple myeloma. We report findings for the Spanish cohort of an open-label treatment protocol that provided ea
Externí odkaz:
https://doaj.org/article/1672ec490b6f4daa88e72c748386ae98
Autor:
Donal Bisanzio, Ashley E. Davis, Sandra E. Talbird, Thierry Van Effelterre, Laurent Metz, Maren Gaudig, Valérie Oriol Mathieu, Anita J. Brogan
Publikováno v:
Vaccine. 41:684-693
Nonpharmaceutical interventions (NPI) and ring vaccination (i.e., vaccination that primarily targets contacts and contacts of contacts of Ebola cases) are currently used to reduce the spread of Ebola during outbreaks. Because these measures are typic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a55269d40f31ab1c6879f704799bd3c9
https://doi.org/10.1016/j.vaccine.2022.11.036
https://doi.org/10.1016/j.vaccine.2022.11.036
Publikováno v:
Future Oncology. 16:859-868
Background: We aimed to elicit treatment preferences in relapsed/refractory mantle cell lymphoma (r/r MCL). Materials & methods: A discrete-choice experiment comprising six attributes (‘overall survival’, ‘progression-free survival’, ‘fatig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1005127954df0830d8f2e8fdeecd047d
https://doi.org/10.2217/fon-2020-0018
https://doi.org/10.2217/fon-2020-0018
Autor:
Vadim V. Ptushkin, Edmond Chan, Maren Gaudig, Adrian Alegre, Matthew Streetly, Maria-Victoria Mateos, Maria Teresa Petrucci, Wafae Iraqi, Alessandro Corso, Assem Al-Akabawi, Gordon Cook, Larisa P. Mendeleeva, Huiling Pei, Jon Ukropec
Publikováno v:
Oncology and Therapy
Introduction Daratumumab is a human IgGκ monoclonal antibody targeting CD38. Despite the demonstrated benefit of daratumumab in multiple myeloma, not all patients have access to commercially available daratumumab. Here we report a pooled analysis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::496fc23bca6ae62dac49a542bef79518
https://eprints.whiterose.ac.uk/183155/6/Cook2021_Article_DaratumumabMonotherapyForRelap.pdf
https://eprints.whiterose.ac.uk/183155/6/Cook2021_Article_DaratumumabMonotherapyForRelap.pdf
Autor:
Pieter Sonneveld, Katja Weisel, Meral Beksac, Maren Gaudig, Andrew Spencer, Maria Rizzo, Annette Lam, Mary Slavcev, L. Dearden, Ying Xin Xu, Kyle Fahrbach
Publikováno v:
Leukemia & Lymphoma, 60(1), 151-162. Informa Healthcare
Treatment history influences the outcomes of subsequent therapies in patients with relapsed or refractory multiple myeloma (RRMM) and needs to be considered when deciding which treatment to use next. To assess the relative merits of immunomodulatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33933b2c0edfeb6b4d64fe075fb4e85
https://hdl.handle.net/1765/112613
https://hdl.handle.net/1765/112613
Autor:
Frida Schain, Maren Gaudig, Kristina Sandström, Annica Dominicus, Christina Victoria Jones, Magnus Björkholm, Christina Loefgren
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::483316dfaa93a59bf0c96fb00067bebc
https://doi.org/10.1016/s2152-2650(21)01332-x
https://doi.org/10.1016/s2152-2650(21)01332-x
Autor:
Maren Gaudig, Kristina Sandstrom, Christina Loefgren, Magnus Björkholm, Annica Dominicus, Frida Schain, Christina Victoria Jones
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S287
Context: There is limited recent population-based data on outcomes for novel agents and different treatment combinations in acute myeloid leukemia (AML) patients judged ineligible for intensive chemotherapy. Objective: To characterize patients, treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60a9a98e11e10216bbd85b9f63a479d4
https://doi.org/10.1016/s2152-2650(21)01688-8
https://doi.org/10.1016/s2152-2650(21)01688-8
Autor:
Josephina G. Kuiper, Christoph Tapprich, Maren Gaudig, Patience Musingarimi, Fernie J. A. Penning-van Beest
Publikováno v:
Journal of Clinical Intensive Care and Medicine. 2:025-033
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d795ac85b50c88e840faa35895bc3d49
https://doi.org/10.29328/journal.jcicm.1001006
https://doi.org/10.29328/journal.jcicm.1001006
Autor:
Maren Gaudig, Bernd Brüggenjürgen, Stefan N. Willich, Nadja Ezzat, J. Burkowitz, Frank Andersohn
Publikováno v:
Journal of Alzheimer's Disease. 54:1365-1372
BACKGROUND The individual and societal burden of Alzheimer's disease (AD) is substantial. Identifying relevant factors deteriorating AD and inducing need for nursing care would be of high relevance for healthcare planning. OBJECTIVE The main objectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e10bdfe01d767c6b60c57eccdd89fd0e
https://doi.org/10.3233/jad-160137
https://doi.org/10.3233/jad-160137